Disease Control Data, nr-axSpA

Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.

Gender Differences in Baseline Clinical Characteristics Among Patients with Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis: Data from 3 Randomized Ixekizumab Controlled Trials - ACR Meeting Abstracts

Non-Radiographic Axial Spondyloarthritis (nr-axSpA) Diagnosis: Symptoms, Tests, and More

Frontiers Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis

Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort

FDA Approval Of The First nr-AxSpA Biologics Projecting Regulatory Market Dynamics

Axial Spondyloarthritis

Access & Patient Support, Axial Spondyloarthritis

Overview of Ankylosing Spondylitis, Clinical Guidance

Monthly improvements in paid work productivity: ankylosing spondylitis

Disease Control Data, nr-axSpA

Frontiers Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO, Arthritis Research & Therapy